Erratum: Effect of increasing glutathione with cysteine and glycine supplementation on mitochondrial fuel oxidation, insulin sensitivity, and body composition in older HIV-infected patients(Journal of Clinical Endocrinology & Metabolism (2014) 99: 1 (169-177) DOI: 10.1210/jc.2013-2376);Effect of increasing glutathione with cysteine and glycine supplementation on mitochondrial fuel oxidation, insulin sensitivity, and body composition in older HIV-infected patients

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 1, 2014, Pages 169-177

  Nguyen, Dan ^a,b   Hsu, Jean W ^c   Jahoor, Farook ^c   Sekhar, Rajagopal V ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Diabetes and Endocrinology Research Center   (United States)

^c AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR PLUS LAMIVUDINE; ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; CYSTEINE; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; GLUTATHIONE; GLYCINE; HEMOGLOBIN; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR;

ADULT; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; CALORIMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; DYNAMOMETRY; FATTY ACID OXIDATION; GLUTATHIONE METABOLISM; GROWTH HORMONE DEFICIENCY; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERINSULINEMIA; INSULIN SENSITIVITY; LIPID ANALYSIS; MALE; MIDDLE AGED; MITOCHONDRIAL RESPIRATION; MUSCLE STRENGTH; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; VIRUS LOAD;

AGE FACTORS; ANTI-HIV AGENTS; BODY COMPOSITION; CYSTEINE; DIETARY SUPPLEMENTS; GLUTATHIONE; GLYCINE; HIV INFECTIONS; HIV-1; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MITOCHONDRIA; OXIDATION-REDUCTION;

EID: 84892181498     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-3004     Document Type: Erratum

References (40)

1. Palella FJ J., Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853-860.
2. Mack KA, Ory MG. AIDS and older Americans at the end of the twentieth century. J Acquir Immune Defic Syndr. 2003;33(Suppl 2):S68-S75.
3. Pathai S, Lawn SD, Shiels PG, et al. Corneal endothelial cells provide evidence of accelerated cellular senescence associated with HIV infection: a case-control study. PLoS One. 2013;8(2):e57422.
4. Martin GE, Gouillou M, Hearps AC, Angelovich TA, Cheng AC, Lynch F, Cheng WJ, Paukovics G, Palmer CS, Novak RM, Jaworowski A, Landay AL, Crowe SM. Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women. PLoS One. 2013;8(1):e55279.
5. Bhatia R, Ryscavage P, Taiwo B. Accelerated aging and human immunodeficiency virus infection: emerging challenges of growing older in the era of successful antiretroviral therapy. J Neurovirol. 2012;18(4):247-255.
6. CDCFact Sheet: HIV/AIDS Among Persons Aged 50 and Older. Centers for Disease Control and Prevention website. http://www.cdc.gov/hiv/pdf/library- factsheet-HIV-among-PersonsAged50andOlder.pdf.
7. Önen NF, Overton ET. A review of premature frailty in HIV-infected persons; another manifestation of HIV-related accelerated aging. Curr Aging Sci. 2011;4(1):33-41.
8. Erlandson KM, Allshouse AA, Jankowski CM, Mawhinney S, Kohrt WM, Campbell TB. Functional impairment is associated with low bone and muscle mass among persons aging with HIV infection. J Acquir Immune Defic Syndr. 2013;1;63(2):209-215.
9. Payne BA, Wilson IJ, Hateley CA, et al. Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mt DNA mutations. Nat Genet. 2011;43(8):806-810.
10. Vassimon HS, Albuquerque de Paula FJ, Machado AA, Monteiro JP, Jordão AA Jr. Hypermetabolism and altered substrate oxidation in HIV-infected patients with lipodystrophy. Nutrition. 2012;28(9): 912-916.
11. Sekhar RV, Jahoor F, White AC, et al. Metabolic basis of HIV lipodystrophy syndrome. Am J Physiol Endocrinol Metab. 2002; 283:E332-E337.
12. Kelley DE, Simoneau JA. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest. 1994;94:2349-2356.
13. Kelley DE, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance: a re-examination. Diabetes. 2000;49(5):667-683.
14. Ghosh S, Pulinilkunnil T, Yuen G, et al. Cardiomyocyte apoptosis induced by short-term diabetes requires mitochondrial GSH depletion. Am J Physiol Heart Circ Physiol. 2005;289:H768-H76.
15. Mastrocola R, Restivo F, Vercellinatto I, et al. Oxidative and nitrosative stress in brain mitochondria of diabetic rats. J Endocrinol. 2005;187:37-44.
16. Nguyen D, Samson SL, Reddy VT, Gonzalez EV, Sekhar RV. Impaired mitochondrial fatty acid oxidation and insulin resistance in aging: novel role of glutathione. Aging Cell. 2013;12(3):415-425.
17. Vassimon HS, Deminice R, Machado AA, Monteiro JP, Jordao AA. The association of lipodystrophy and oxidative stress biomarkers in HIV-infected men. Curr HIV Res. 2010;8(5):364-369.
18. Sbrana E, Paladini A, Bramanti E, Spinetti MC, Raspi G. Quantitation of reduced glutathione and cysteine in human immunodeficiency virus-infected patients. Electrophoresis. 2004;25(10-11): 1522-1529.
19. Nakamura H, Masutani H, Yodoi J. Redox imbalance and its control in HIV infection. Antioxid Redox Signal. 2002;4(3):455-464.
20. Sekhar RV, McKay SV, Guthikonda AP, Patel SG, Reddy VT, Balasubramanyam A, Jahoor F. Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. Diabetes Care. 2011;34(1): 162-167.
21. Sekhar RV, Patel SG, Guthikonda AP, et al. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am J Clin Nutr. 2011;94(3):847-853.
22. Sekhar RV, Patel SG, D'Amico S, et al. Effects of rosiglitazone on abnormal lipid kinetics in HIV-associated dyslipidemic lipodystrophy: a stable isotope study. Metabolism. 2011;60(6):754-760.
23. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol. 1983;55:628-634.
24. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-E223.
25. Reeds DN, Cade WT, Patterson BW, Powderly WG, Klein S, Yarasheski KE. Whole-body proteolysis rate is elevated in HIV associated insulin resistance. Diabetes. 2006;55(10):2849-2855.
26. Galgani JE, Moro C, Ravussin E. Metabolic flexibility and insulin resistance. Am J Physiol Endocrinol Metab. 2008;295(5):E1009-E1017.
27. Storlien L, Oakes ND, Kelley DE. Metabolic flexibility. Proc Nutr Soc. 2004;63(2):363-368.
28. Ortmeyer H, Ryan A, Hafer-Macko C, Oursler KA. Reduced skeletal muscle mitochondrial function in older HIV-infected men is associated with low aerobic exercise capacity. In: Proceedings from the 19th International AIDS Conference; July 22-27, 2012; Washington, DC. Abstract WEPE091.
29. Chakravarti B, Chakravarti DN. Oxidative modification of proteins: age-related changes. Gerontology. 2007;53(3):128-139.
30. Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 2003; 17(10):1195-1214.
31. Evans MD, Dizdaroglu M, Cooke MS. Oxidative DNA damage and disease: induction, repair and significance. Mutation Res. 2004; 567(1):1-61.
32. Richter C. Oxidative damage to mitochondrial DNA and its relationship to ageing. Int J Biochem Cell Biol. 1995;27:647-653.
33. Wallace DC, Ye JH, Neckelmann SN, Singh G, Webster KA, Greenberg BD. Sequence analysis of cDNAs for the human and bovine ATP synthase beta subunit: mitochondrial DNA genes sustain seventeen times more mutations. Curr Genet. 1987;12:81-90.
34. Zurlo F, Lillioja S, Esposito-Del Puente A, et al. Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol. 1990;259(5):E650-657.
35. Corpeleijn E, Saris WH, Blaak EE. Metabolic flexibility in the development of insulin resistance and type 2 diabetes: effects of lifestyle. Obes Rev. 2009;10(2):178-193.
36. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes. 1997;46(1):3-10.
37. Mouzannar R, McCafferty J, Benedetto G, Richardson C. Transcriptional and phospho-proteomic screens reveal stem cell activation of insulin resistance and transformation pathways following a single minimally toxic episode of ROS. Int J Genomics Proteomics. 2011;2(1):34-49.
38. Bloch-Damti A, Bashan N. Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid Redox Signal. 2005;7(11-12):1553-1567.
39. Karnieli E, Armoni M. Transcriptional regulation of the insulinresponsive glucose transporter GLUT4 gene: from physiology to pathology. Am J Physiol Endocrinol Metab. 2008;295(1):E38-E45.
40. Peters MJ, van Nes SI, Vanhoutte EK, et al; PeriNomS Study Group. Revised normative values for grip strength with the Jamar dynamometer. J Peripher Nerv Syst. 2011;16(1):47-50.